Troluce Capital Advisors »

Viking Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.9M 172k 40.24

More positions owned by Troluce Capital Advisors

Fluor Corporation Call Option (FLR)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Kenvue (KVUE)
Honeywell International Call Option (HON)
Echostar Corp Cl A (SATS)
Capital One Financial (COF)
Dupont De Nemours (DD)
Oklo Com Cl A Put Option (OKLO)
Golar Lng SHS Call Option (GLNG)
EXACT Sciences Corporation Call Option (EXAS)
Amcor Ord (AMCR)
Standardaero (SARO)
Intel Corporation Call Option (INTC)
Equinix (EQIX)
U Haul Holding Company Com Ser N (UHAL.B)

View all positions for Troluce Capital Advisors

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics